COTY INC. quarterly report, Q2 FY2021

Coty Inc. — Form 10-Q Summary

Business context and period. Coty manufactures and sells beauty products globally. This report covers the quarter and six months ended December 31, 2020 (fiscal Q2 and first half of fiscal 2021); comparisons are with the corresponding 2019 periods. Results are presented for continuing operations unless noted. The Wella Professional and Retail Hair businesses are reported as discontinued operations following Coty’s November 30, 2020 sale of a 60% stake to KKR.

Financial results

MetricThree months ended Dec. 31Six months ended Dec. 31
Continuing-operations revenue$1,415.6 million, down 15.9%$2,539.7 million, down 17.9%
Gross profit / gross margin$831.6 million / 58.7%, versus $1,051.4 million / 62.4%$1,490.8 million / 58.7%, versus $1,900.7 million / 61.4%
Operating income (loss)$17.0 million, versus $(80.5) million$(49.0) million, versus $(16.5) million
Adjusted operating income (non-GAAP)$188.4 million, up 7%; 13.3% margin$269.5 million, up 11%; 10.6% margin
Net income (loss) attributable to Coty Inc.$(252.3) million, versus $(21.1) million$(30.9) million, versus $31.2 million
Net loss attributable to common stockholders / EPS$(275.4) million / $(0.36) per share$(74.8) million / $(0.10) per share
Operating cash flowNot presented separately in the supplied filing text$472.7 million, versus $462.0 million
  • Reported results include Wella discontinued-operations losses of $235.6 million for the quarter and $130.9 million for the six months, including a $219.1 million loss on sale. Continuing-operations net income was $(19.0) million for the quarter and $103.6 million for the six months; the latter included a substantial tax benefit.
  • Cash and cash equivalents were $549.1 million at December 31, 2020; restricted cash was $56.2 million. Total debt was $5.392 billion, compared with $8.156 billion at June 30, 2020. Coty reported immediate liquidity of $2.832 billion, including available revolving credit.
  • Following the Wella transaction, Coty reported financial net debt of $4.843 billion and economic net debt of approximately $3.656 billion after subtracting the stated fair value of its retained Wella interest. The Wella investment was valued at $1.187 billion at quarter-end, down from its initial $1.635 billion fair value at closing.

Changes versus the prior period

  • Continuing-operations revenue declined across all regions, reflecting pandemic-related restrictions, lower retail and travel-retail traffic, and weaker demand, particularly for color cosmetics and mass fragrance. E-commerce growth and selected fragrance launches partly offset declines.
  • Quarterly operating results improved from a loss to income, aided by lower restructuring, advertising and promotional, and other discretionary costs. However, gross margin contracted, and first-half operating loss widened as lower sales, mix, inventory obsolescence, amortization, and transaction costs weighed on results.
  • Adjusted operating income and margin increased in both comparison periods, but these non-GAAP measures exclude significant costs; they should be considered alongside GAAP results.
  • The Wella sale generated $2.452 billion of gross cash proceeds for the 60% stake. Coty used $2.016 billion of net proceeds to repay term loans and reserved $500 million for reinvestment. Coty also received a $448 million return of capital from Wella and retained a 40% interest.

Outlook, commentary and risks

  • Management said COVID-19 continued to materially affect categories, regions and channels, with recovery expected to be gradual and uneven. No numerical revenue or earnings guidance is provided in the supplied filing text.
  • The Transformation Plan targets revenue stabilization and growth, improved margins and cost control, operating-model changes, digital and e-commerce growth, and debt reduction. Management said Coty was on track to exit fiscal 2021 with more cost savings than initially anticipated; approximately $80 million of additional restructuring charges were expected over the next three fiscal years.
  • The company stated that it had sufficient liquidity and covenant headroom for foreseeable operating and recurring cash needs. Its minimum-liquidity covenant was $500 million; immediate liquidity was $2.832 billion. The net-leverage covenant was not tested through March 31, 2021 under the amended credit agreement. Coty reported compliance with applicable covenants at December 31, 2020.
  • A preliminary $220.5 million tax benefit related to Coty’s principal-location move from Geneva to Amsterdam contributed to first-half continuing-operations income and the unusually high reported effective tax rate. The benefit remained subject to finalization through discussions with tax authorities.
  • The board had suspended common dividends; management expected suspension through April 1, 2021 or until the specified net-debt-to-Adjusted-EBITDA threshold was reached, subject to board discretion. Series B preferred stock carries a 9% annual cumulative dividend and may dilute common shareholders upon conversion.
  • Key risks include the duration and effects of COVID-19, execution of the transformation and cost-savings plans, high debt and refinancing needs, consumer and channel trends, foreign exchange, and integration or transaction risks. The filing also describes securities and trade-secret litigation and significant Brazilian tax assessments; Coty said it believed its defenses were meritorious and had not accrued losses for those assessments because loss was not considered probable.

Important facts for investors to verify

  • How continuing-operations sales, gross margin, and segment performance evolve as pandemic restrictions and travel retail conditions change.
  • Whether planned transformation savings are achieved and what cash restructuring costs and other excluded items remain.
  • The final Wella sale consideration and any post-closing working-capital adjustments, as well as the fair value and performance of Coty’s retained 40% investment.
  • Debt repayment, use of the $500 million reinvestment reserve, covenant requirements, and the distinction between financial and economic net debt.
  • The resolution of the preliminary tax benefit, ongoing tax uncertainties, Brazilian assessments, and other disclosed litigation.
  • The impact of Series B preferred dividends and potential conversion dilution on common-shareholder earnings and value.